Granted Patent B2

US 6,939,879 · App. 10/609,751 · Granted Sep 6, 2005

Abstract

Claims (14)

1. A method of providing symptomatic relief from substance induced insomnia in a patient comprising administering to said patient a therapeutically effective amount of R-(+)-α-(2,3-dimethoxphenyl)-1-[2-(4-fluoropheyl)ethyl]-4-piperidinemethanol or a pharmaceutically acceptable salt thereof wherein said substance is selected from the group consisting of caffeine, alcohol, amphetamine, opioids, sedatives, hypnotics and anxiolytics.

2. The method of claim 1 wherein the substance is caffeine.

3. The method of claim 1 wherein wherein the substance is alcohol.

4. The method of claim 1 wherein the substance is amphetamine.

5. The method of claim 1 wherein the substance is an opiod.

6. The method of claim 1 wherein the substance is a sedative.

7. The method of claim 1 wherein the substance is a hypnotic.

8. The method of claim 1 wherein the substance is an anxiolytic.

9. A method of providing symptomatic relief from alcohol induced insomnia in a patient comprising administering to said patient a therapeutically effective amount of R-(+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol or a pharmaceutically acceptable salt thereof.

10. The method of claim 9 wherein alcohol induced insomnia is caused by effects of taking alcohol.

11. The method of claim 9 wherein alcohol induced insomnia is caused by effects of withdrawing from alcohol.

12. A method of providing symptomatic relief from caffeine induced insomnia in a patient comprising administering to said patient a therapeutically effective amount of R-(+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol or a pharmaceutically acceptable salt thereof.

13. The method of claim 12 wherein alcohol induced insomnia is caused by effects of taking caffeine.

14. The method of claim 12 wherein alcohol induced insomnia is caused by effects of withdrawing from caffeine.

Assignments (10)